Oncology is the largest pharma market and among most competitive. Despite huge progress, large unmet medical needs remain. Increasingly...

With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and...

Checkpoint inhibitors against PD-1, PD-L1, CTLA-4 are dramatically improving cancer treatment in defined patient sub-sets. Combining...